Mesothelioma in Women

Mesothelioma in women represents a distinct clinical and epidemiological profile compared to mesothelioma in men. While malignant mesothelioma predominantly affects males due to higher rates of occupational asbestos exposure, approximately 20–25% of all cases occur in women, translating to roughly 600–700 new diagnoses annually in the United States. Women with mesothelioma often have different exposure histories and, in many cases, demonstrate better treatment outcomes than their male counterparts.¹

The most significant difference in mesothelioma among women is the exposure pathway. While men are more commonly exposed through occupational settings such as construction, shipbuilding, and industrial trades, women are disproportionately affected by take-home exposure (also called secondhand or paraoccupational exposure), in which asbestos fibers are carried into the home on a worker's clothing, hair, or skin. Additionally, women face unique exposure risks from asbestos-contaminated cosmetic talc products, including talcum powder and certain cosmetics, which has been the subject of significant litigation.²

Women develop peritoneal mesothelioma at a proportionally higher rate than men. While pleural mesothelioma still accounts for the majority of cases in both sexes, the peritoneal-to-pleural ratio is higher among women. This is clinically significant because peritoneal mesothelioma treated with cytoreductive surgery and HIPEC has markedly better survival rates than pleural disease.³

Multiple studies have demonstrated that women with mesothelioma tend to survive longer than men with comparable disease stage and cell type. The reasons for this survival advantage are not fully understood but may include hormonal factors, differences in immune response, and the higher proportion of peritoneal disease. Women diagnosed with mesothelioma should be aware of their legal options for compensation, including claims related to take-home exposure and contaminated talcum powder products.

Symptoms of mesothelioma in women are similar to those in men and depend on the type:

• Pleural mesothelioma — shortness of breath, chest pain, persistent cough, pleural effusion
• Peritoneal mesothelioma — abdominal pain, bloating, ascites, changes in bowel habits, unexplained weight loss
• General — fatigue, loss of appetite, unexplained weight loss, night sweats

Symptoms in women may be initially attributed to more common conditions such as ovarian cancer, irritable bowel syndrome, or respiratory infections, potentially delaying diagnosis.¹

Asbestos exposure is the primary cause of mesothelioma in women, though the routes of exposure differ from those typically seen in men:

• Take-home exposure — laundering asbestos-contaminated work clothes or close contact with an asbestos worker; this is the most common route for women
• Cosmetic talc — some talcum powder and cosmetic products were contaminated with asbestos fibers, particularly products mined from certain deposits
• Environmental exposure — living near asbestos mines, processing facilities, or naturally occurring asbestos deposits
• Occupational exposure — women working in industries such as textiles, education (older buildings), and manufacturing
• Unknown exposure — a proportion of women with mesothelioma have no identifiable asbestos exposure history

Risk factors for mesothelioma in women include:

• Living with an asbestos worker — take-home exposure is the most well-documented risk factor for women
• Use of asbestos-contaminated talc products — long-term use of contaminated talcum powder
• Environmental proximity — residing near asbestos mining or processing operations
• Occupational asbestos exposure — certain industries employed women in asbestos-exposed settings
• BAP1 germline mutation — inherited genetic predisposition that increases mesothelioma risk regardless of gender
• Prior radiation therapy — previous thoracic or abdominal radiation may increase risk

Diagnosis of mesothelioma in women follows the same clinical pathway as in men, though certain considerations apply:

• Imaging — CT scan of the chest and/or abdomen is typically the initial diagnostic study
• Biopsy — tissue diagnosis with immunohistochemical staining is required for definitive diagnosis
• Differential diagnosis — peritoneal mesothelioma in women must be distinguished from ovarian cancer, primary peritoneal carcinoma, and other gynecological malignancies
• Exposure history — clinicians should specifically ask about take-home exposure, cosmetic talc use, and environmental exposure, as women may not recognize these as asbestos-related risks

Women with mesothelioma generally have a better prognosis than men:

• Multiple large-scale studies show that female sex is an independent positive prognostic factor for mesothelioma survival
• The median survival advantage for women over men is estimated at several months when controlling for other factors
• The higher proportion of peritoneal mesothelioma in women contributes to better overall survival, as peritoneal disease treated with HIPEC has 5-year survival rates approaching 50%
• Hormonal and immunological differences may partly explain the survival advantage, though this remains an area of active research

Prevention strategies specific to mesothelioma risk in women include:

• Avoiding laundering asbestos-contaminated work clothing at home — asbestos workers should change and shower at the workplace
• Choosing asbestos-free cosmetic and personal care products — look for products tested for asbestos contamination
• Being aware of environmental asbestos risks if living near mining or processing areas
• Informing healthcare providers of any known asbestos exposure history, including secondhand exposure